Earningsreport

Q2/2024 3/31/2024 EPS -0.050 ZacksConsensus -0.060 ActVsEst 0.010 - Beat

Citius Pharmaceuticals, Inc.  (CTXR) 
NASDAQ:AMEX Investor Relations: ir.citiuspharma.com